37
In band
Moving averages
SMA 200$5.56-45.50%
Company profile
Ardelyx, Inc., a biopharmaceutical company, develops and sells drugs for the treatment of kidney and cardiorenal diseases in the United States and internationally. The company is headquartered in Fremont, California.
SectorHealthcare
IndustryBiotechnology
Market cap$833.95M
P/E ratioNone
EPS$-0.23
Beta0.678
Dividend yield0.00%
52-week high$8.40
52-week low$3.09
Similar stocks in Biotechnology
BNTX
BioNTech SE
RSI 41
VRTX
Vertex Pharmaceuticals Inc
RSI 68
CRSP
CRISPR Therapeutics AG
RSI 48
IOVA
Iovance Biotherapeutics Inc
RSI 30
DNA
Ginkgo Bioworks Holdings Inc - Class A
RSI 52
GERN
Geron Corp
RSI 22
CADL
Candel Therapeutics Inc
RSI 38
ANRO
Alto Neuroscience Inc
RSI 40
GHRS
GH Research PLC
RSI 48
ALT
Altimmune Inc
RSI 27
RSI alerts for ARDX
An email when ARDX closes below RSI 30 or above 70. Nothing else.
Add alertData last updated 13 October 2026 at 9:53 PM EDT